A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
Public ClinicalTrials.gov record NCT06634797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Observer-blind, Placebo-controlled, Crossover Study to Assess Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess cardiac troponin I (cTnI) values in participants who received mRNA-1273.712 or placebo.
Study identification
- NCT ID
- NCT06634797
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 30 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 8, 2024 (Actual)
- Primary completion
- Jan 20, 2025 (Actual)
- Completion
- Jan 20, 2025 (Actual)
- Last update posted
- Feb 4, 2026
2024 – 2025
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research, Phoenix | Phoenix | Arizona | 85006 | — |
| Velocity Clinical Research, Huntington Park | Huntington Park | California | 90255 | — |
| Velocity Clinical Research, San Diego | La Mesa | California | 91942 | — |
| Velocity Clinical Research, Banning | San Bernardino | California | 82408 | — |
| Velocity Clinical Research, Washington DC | Washington D.C. | District of Columbia | 20016 | — |
| Velocity Clinical Research, Savannah | Savannah | Georgia | 31406 | — |
| Velocity Clinical Research, Boise | Meridian | Idaho | 83642 | — |
| Velocity Clinical Research, Valparaiso | Valparaiso | Indiana | 46383 | — |
| Velocity Clinical Research, Covington | Covington | Louisiana | 70433 | — |
| Velocity Clinical Research, Lafayette | Lafayette | Louisiana | 70508 | — |
| Velocity Clinical Research, New Orleans | New Orleans | Louisiana | 70119 | — |
| Velocity Clinical Research, Gulfport | Gulfport | Mississippi | 39503 | — |
| Velocity Clinical Research, Grand Island | Grand Island | Nebraska | 68803 | — |
| Velocity Clinical Research, Lincoln | Lincoln | Nebraska | 68510 | — |
| Velocity Clinical Research, Omaha | Omaha | Nebraska | 68134 | — |
| Velocity Clinical Research, Albuquerque | Albuquerque | New Mexico | 87107 | — |
| Velocity Clinical Research, Syracuse | East Syracuse | New York | 13057 | — |
| Velocity Clinical Research, Durham | Durham | North Carolina | 27701 | — |
| Velocity Clinical Research, Cleveland | Beachwood | Ohio | 44122 | — |
| Velocity Clinical Research, Cincinnati, Blue Ash | Blue Ash | Ohio | 45242 | — |
| Velocity Clinical Research, Cincinnati | Cincinnati | Ohio | 45246 | — |
| Velocity Clinical Research, Anderson | Anderson | South Carolina | 29621 | — |
| Velocity Clinical Research, Abilene | Abilene | Texas | 79606 | — |
| Velocity Clinical Research, Salt Lake City | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06634797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06634797 live on ClinicalTrials.gov.